All Online

1 - 12 of 31 results

Refine

Active filters

Pediatrics
vector of purple ribbons coiling
0.5 CME CREDIT

There is much controversy and confusion over when treatment with human growth hormone (rhGH) for short stature in children should be considered. This activity will focus on which children and conditions which may benefit from treatment, the FDA approved criteria for treating idiopathic short stature (ISS), efficacy, cost, and safety of rhGH treatment.


0.75 CME CREDIT

Sports Concussion in Children 

Up to 0.75 CME CREDIT

Dr. Chris Giza, Director of the UCLA Steve Tisch BrainSPORT Program and a Professor of Pediatric Neurology at UCLA will review evidence-based management for youth sports concussion. He will discuss epidemiology of sports concussions in children, diagnosis, and recommended management including recent updates in the field of concussion management in young children. He will also review the current evidence for controversies in concussion including second impact syndrome, cognitive rest and chronic neurocognitive impairment.


suited man with his head in a cloud
0.5 CME CREDIT

ADHD is a rising concern in children and adolescents. In this activity, learn about effectively treating ADHD in the presence of comorbid conditions such as depression and anxiety disorders. Dr. Cummins also explains management strategies for dealing with side effects normally associated with stimulants prescribed for ADHD.


1 CME CREDIT

In this lecture, Dr. Wurm will review recent studies on nutrition and integrative pediatrics including ones on dietary interventions, exercise programs and meditation. Effective strategies to implement these into practice to reduce pediatric obesity will be discussed.


0.75 CME CREDIT

Discuss how to improve understanding of current best practices in diagnosis of IgE and non-IgE mediated food allergy. Dr. Shreffler will go over strategies to raise awareness of the unmet needs in food allergy management. He will also discuss state of the research on food allergy treatment and the identification of surrogates for clinical efficacy.


1.03 CME CREDITS

Get the latest updates on the new clinical practice guidelines for food allergies management by the NIAID. Learn about the definition of food allergy and how to differentiate between allergy and intolerance. The faculty will also discuss the management of acute and non-acute allergic reactions and review prevention strategies.


dictionary definition of ADHD
1 CME CREDIT

Attention deficit/hyperactivity disorder is a common condition in children and adolescents, requiring careful diagnosis and targeted treatment. In this session, learn how to identify the core symptoms of ADHD; how to select and sequence stimulant and non-stimulant medication, based on symptom presentation; and when psychosocial interventions are appropriate.


Is it child abuse?
1 CME CREDIT

Is It Child Abuse?

Up to 1 CME CREDIT

This program will review the signs of child abuse including physical and sexual abuse, neglect, psychological maltreatment and medical child abuse. This discussion will include the dynamics of child sexual abuse and how it differs from acute sexual assault. Requirements for reporting reasonable suspicion of abuse will also be discussed.   


person cutting their wrists with small razor blade
0.5 CME CREDIT

Rachel Ballard, MD reviews risk factors for nonsuicidal self-injury (NSSI) behaviors and tools for assessing NSSI risk in the primary care practice.


post-vaccination band-aid

In this brief activity, Dr. Jeffrey Brosco provides clinical pearls for increasing vaccine acceptance during office visits in primary care practices by addressing some common concerns among parents, such as autism and side effects of vaccines.


0.5 CME CREDIT

Dr. Caroline Apovian, one of the foremost experts on weight loss in the U.S., discusses the problem of childhood and adolescent obesity and offers some clinical pearls for primary care clinicians to use in their practices.


0.25 CME CREDIT

In this brief activity, Dr. Jennifer Strople presents clinical data and discusses the risks and benefits of biologic and immunomodulator therapies for the treatment of pediatric inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.